Live Breaking News & Updates on Fda Reports Increase

The last decade has seen a “dramatic increase” in investigational new drug (IND) applications for cannabis-derived products, according to the U.S. Food and Drug Administration.

....

Schuyler Pruyn , Cassandra Taylor , Viola Brugnatelli , Drug Administration , Cannabis Drug Development , Most Prevalent Areas Of Research , National Institute On Drug Abuse , Drug Development , Drug Evaluation , Prevalent Areas , Clinical Cannabinology , National Institute , Botanical Drug Development , Cannabis Derived Compounds , Quality Considerations , Clinical Researchguidance , Us Food And Drug Administration , Fda Reports Increase ,